<p>添加</p>
<p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png"/></p>
<p>将其添加为您在 Google 上的首选新闻来源</p>
<p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/google.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/google.png"/></p>
<p>立即添加</p>
<p>Evotec SE (EVO,EVTG.DE,EVTCY.PK) 是一家生命科学公司，周五宣布其首席财务官 Paul Hitchin 将于 4 月 30 日离职，&#34;因与 Evotec 无关的个人原因。&#34;</p>
<p>Claire Hinshelwood 已被任命为新的首席财务官，任职将于 5 月 1 日生效，公司在一份声明中表示。</p>
<p>Hinshelwood 拥有超过 30 年的财务领导经验，最近在 BMI 集团担任首席财务官。</p>
<p>在纳斯达克，Evotec 的股票在盘后交易中上涨了 1.55%，报 3.28 美元，此前周四常规交易收于 3.23 美元。</p>
<p>如有意见和反馈，请联系：editorial@rttnews.com</p>
<p>商业新闻</p>

IBBQ

纳斯达克生物科技指数 ETF - iShares Nasdaq

医药突破 ETF - ALPS

2 倍做多纳斯达克生物技术 ETF - ProShares

标普生物技术 3 倍做多 - Direxion

标普生物技术 ETF - SPDR

动态生物技术与基因组 ETF - Invesco

生物科技 ETF - VanEck Vectors

<p>Evotec SE 宣布首席财务官 Paul Hitchin 因个人原因辞职，辞职日期为 4 月 30 日。Claire Hinshelwood 将于 5 月 1 日接任首席财务官。Hinshelwood 拥有超过 30 年的财务领导经验，曾担任 BMI Group 的首席财务官。在公告发布后，Evotec 的股价在盘后交易中上涨了 1.55%，至 3.28 美元</p>

<p>Add</p>
<div class="lb-trans"><p>添加</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png" alt="" original-src="https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png"/></p>
<p>as your preferred news source on Google</p>
<div class="lb-trans"><p>将其添加为您在 Google 上的首选新闻来源</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/google.png" alt="" original-src="https://cdn.rttnews.com/images/v4/google.png"/></p>
<p>Add Now</p>
<div class="lb-trans"><p>立即添加</p>
</div><p>Evotec SE (EVO,EVTG.DE,EVTCY.PK), a life science company, announced Friday that its CFO Paul Hitchin will leave the company on April 30, &#34;citing personal reasons unrelated to Evotec.&#34;</p>
<div class="lb-trans"><p>Evotec SE (EVO,EVTG.DE,EVTCY.PK) 是一家生命科学公司，周五宣布其首席财务官 Paul Hitchin 将于 4 月 30 日离职，&#34;因与 Evotec 无关的个人原因。&#34;</p>
</div><p>Claire Hinshelwood has been named the new financial chief effective May 1, the company said in a statement.</p>
<div class="lb-trans"><p>Claire Hinshelwood 已被任命为新的首席财务官，任职将于 5 月 1 日生效，公司在一份声明中表示。</p>
</div><p>Hinshelwood has over 30 years of financial leadership experience and was most recently served at BMI Group as CFO.</p>
<div class="lb-trans"><p>Hinshelwood 拥有超过 30 年的财务领导经验，最近在 BMI 集团担任首席财务官。</p>
</div><p>On the Nasdaq, shares of Evotec were gaining 1.55 percent after hours at $3.28 after closing Thursday's regular trading at $3.23.</p>
<div class="lb-trans"><p>在纳斯达克，Evotec 的股票在盘后交易中上涨了 1.55%，报 3.28 美元，此前周四常规交易收于 3.23 美元。</p>
</div><p>For comments and feedback contact: editorial@rttnews.com</p>
<div class="lb-trans"><p>如有意见和反馈，请联系：editorial@rttnews.com</p>
</div><p>Business News</p>
<div class="lb-trans"><p>商业新闻</p>
</div>

Evotec CFO Paul Hitchin Resigns; Names Claire Hinshelwood Replacement

rttnews

Evotec SE

Invesco Nasdaq Biotechnology ETF

纳斯达克 OMX 交易所

Evotec 的首席财务官 Paul Hitchin 辞职，任命 Claire Hinshelwood 为其继任者